PharmaEngine (ROCO:4162) Total Assets : NT$4,058.7 Mil (As of Sep. 2024)

View and export this data going back to 2012. Start your Free Trial

What is PharmaEngine Total Assets?

PharmaEngine's Total Assets for the quarter that ended in Sep. 2024 was NT$4,058.7 Mil.

During the past 12 months, PharmaEngine's average Total Assets Growth Rate was -8.00% per year. During the past 3 years, the average Total Assets Growth Rate was -26.30% per year. During the past 5 years, the average Total Assets Growth Rate was 7.10% per year. During the past 10 years, the average Total Assets Growth Rate was 25.10% per year.

During the past 13 years, PharmaEngine's highest 3-Year average Total Assets Growth Rate was 162.30%. The lowest was -26.30%. And the median was 19.45%.

Total Assets is connected with ROA %. PharmaEngine's annualized ROA % for the quarter that ended in Sep. 2024 was 8.91%. Total Assets is also linked to Revenue through Asset Turnover. PharmaEngine's Asset Turnover for the quarter that ended in Sep. 2024 was 0.05.

PharmaEngine Total Assets Historical Data

The historical data trend for PharmaEngine's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaEngine Total Assets Chart

PharmaEngine Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

3,643.39

4,206.91

4,026.34

3,966.54

3,953.92

PharmaEngine Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Assets	Get a 7-Day Free Trial															3,899.89	3,953.92	4,062.67	4,216.67	4,058.66

PharmaEngine Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

PharmaEngine's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	3862.913	+	91.006
	=	3,953.9

PharmaEngine's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2024 )	+	Total Liabilities (Q: Sep. 2024 )
	=	3981.418	+	77.245
	=	4,058.7

PharmaEngine (ROCO:4162) Total Assets Explanation

Total Assets is connected with ROA %.

PharmaEngine's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %	=	Net Income (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	368.684	/	( (4216.672	+	4058.663)	/ 2 )
	=	368.684	/	4137.6675
	=	8.91 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

PharmaEngine's Asset Turnover for the quarter that ended in Sep. 2024 is

	Asset Turnover
=	Revenue (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
=	218.224	/	( (4216.672	+	4058.663)	/ 2 )
=	218.224	/	4137.6675
=	0.05

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

PharmaEngine Total Assets Related Terms

Thank you for viewing the detailed overview of PharmaEngine's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaEngine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaEngine Inc (ROCO:4162) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 Minsheng East Road, 11th Floor, Section 3, Taipei, TWN, 104

Website

https://www.pharmaengine.com

PharmaEngine Inc is a biopharmaceutical company engaged in the development of new drugs and therapeutic drugs for cancer. It is a specialty pharma company that adopts the no research, development-only model and the networked pharma model for new drug development. Its projects pipeline are: ONIVYDE was approved by the U.S. FDA, Taiwan FDA, and EMA for patients with gemcitabine-treated metastatic pancreatic cancer; and PEP07. It generates the revenue from Sales of goods.

PharmaEngine Headlines

No Headlines